Fractures and breakages of the helix on the Rotarex system has led to 30 serious injuries, four deaths, and 115 interventions ...

AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Our mission is still to take care of our patients, to provide them the best care that we can, and that’s what we are ...

AngioDynamics initiates the AMBITION BTK RCT and registry to advance treatment for patients with chronic limb-threatening ischemia and below-the-knee peripheral artery disease.

Tammie Finley is enjoying pain-free life again thanks to a procedure performed by Adena Heart and Vascular Institute surgeon ...

Atherectomy Devices, Bioresorbable Vascular Scaffolds), By Procedure Type (Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve ...

AngioDynamics, Inc. announced the commencement of the AMBITION BTK multicenter randomized controlled trial (RCT), which will ...

AngioDynamics (ANGO) announced the start of a randomized study of the Auryon Atherectomy System used in combination with Standard Balloon ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options ...

The following is a summary of “Comparative Outcomes of Left Main and Non-Left Main Percutaneous Coronary Intervention from the Excellence in Coronary Artery Disease (XLCAD) Registry,” published in the ...

The Phoenix atherectomy system combines the benefits of existing atherectomy systems to deliver a unique, hybrid atherectomy option to help physicians tailor the treatment approach for each patient.